QS Investors LLC decreased its holdings in shares of Cigna Corp (NYSE:CI) by 15.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 77,273 shares of the health services provider’s stock after selling 13,661 shares during the period. QS Investors LLC’s holdings in Cigna were worth $14,676,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the stock. AIMZ Investment Advisors LLC lifted its stake in Cigna by 44.0% during the fourth quarter. AIMZ Investment Advisors LLC now owns 11,665 shares of the health services provider’s stock worth $2,215,000 after purchasing an additional 3,565 shares during the last quarter. Claybrook Capital LLC bought a new stake in Cigna during the fourth quarter worth about $34,000. Mosaic Family Wealth LLC bought a new stake in Cigna during the fourth quarter worth about $241,000. MUFG Securities EMEA plc lifted its stake in Cigna by 821.2% during the fourth quarter. MUFG Securities EMEA plc now owns 60,781 shares of the health services provider’s stock worth $11,544,000 after purchasing an additional 54,183 shares during the last quarter. Finally, Maven Securities LTD bought a new stake in Cigna during the fourth quarter worth about $230,000. 93.44% of the stock is owned by institutional investors.

In related news, insider Michael W. Triplett sold 9,148 shares of the business’s stock in a transaction dated Monday, February 11th. The stock was sold at an average price of $181.01, for a total transaction of $1,655,879.48. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director William D. Zollars sold 272 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $168.43, for a total value of $45,812.96. The disclosure for this sale can be found here. In the last three months, insiders sold 10,420 shares of company stock valued at $1,886,122. 1.10% of the stock is currently owned by corporate insiders.

Several equities research analysts have issued reports on CI shares. Credit Suisse Group reaffirmed a “buy” rating and set a $250.00 price target on shares of Cigna in a research note on Monday, January 7th. Barclays reaffirmed a “buy” rating and set a $220.00 price target on shares of Cigna in a research note on Sunday, January 6th. Zacks Investment Research raised Cigna from a “hold” rating to a “buy” rating and set a $208.00 price target for the company in a research note on Friday, January 4th. Edward Jones started coverage on Cigna in a research note on Wednesday, January 2nd. They set a “buy” rating for the company. Finally, Goldman Sachs Group reaffirmed a “buy” rating on shares of Cigna in a research note on Saturday, February 2nd. One research analyst has rated the stock with a sell rating, three have given a hold rating and thirteen have given a buy rating to the stock. Cigna has an average rating of “Buy” and an average price target of $231.28.

NYSE CI opened at $166.45 on Friday. Cigna Corp has a 1-year low of $162.42 and a 1-year high of $226.60. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.42 and a quick ratio of 0.42. The stock has a market capitalization of $63.26 billion, a PE ratio of 11.71, a P/E/G ratio of 0.81 and a beta of 0.73.

Cigna (NYSE:CI) last released its earnings results on Friday, February 1st. The health services provider reported $2.46 earnings per share for the quarter, missing analysts’ consensus estimates of $2.53 by ($0.07). Cigna had a net margin of 5.42% and a return on equity of 16.64%. The company had revenue of $13.75 billion during the quarter, compared to the consensus estimate of $11.38 billion. During the same period last year, the firm posted $1.94 EPS. The company’s revenue was up 29.3% on a year-over-year basis. Equities research analysts forecast that Cigna Corp will post 16.41 earnings per share for the current year.

The business also recently announced a special dividend, which will be paid on Wednesday, April 10th. Stockholders of record on Monday, March 11th will be paid a $0.04 dividend. The ex-dividend date of this dividend is Friday, March 8th. Cigna’s dividend payout ratio (DPR) is presently 0.28%.

COPYRIGHT VIOLATION NOTICE: “Cigna Corp (CI) Shares Sold by QS Investors LLC” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at https://www.watchlistnews.com/cigna-corp-ci-shares-sold-by-qs-investors-llc/2897747.html.

Cigna Company Profile

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Story: What is Liquidity?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.